BLRCX
Price
$10.91
Change
-$0.39 (-3.45%)
Updated
Dec 18 closing price
GRSRX
Price
$50.75
Change
-$1.80 (-3.43%)
Updated
Dec 18 closing price
Ad is loading...

BLRCX vs GRSRX

Header iconBLRCX vs GRSRX Comparison
Open Charts BLRCX vs GRSRXBanner chart's image
Brookfield Global Listed Real Estate C
Price$10.91
Change-$0.39 (-3.45%)
VolumeN/A
CapitalizationN/A
Cohen & Steers Global Realty R
Price$50.75
Change-$1.80 (-3.43%)
VolumeN/A
CapitalizationN/A
BLRCX vs GRSRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BLRCX vs. GRSRX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRCX is a Hold and GRSRX is a Sell.

FUNDAMENTALS
Fundamentals
GRSRX has more cash in the bank: 1.92B vs. BLRCX (159M). GRSRX pays higher dividends than BLRCX: GRSRX (2.46) vs BLRCX (1.60). BLRCX was incepted earlier than GRSRX: BLRCX (13 years) vs GRSRX (10 years). BLRCX is a more actively managed with annual turnover of: 91.00 vs. GRSRX (52.00). GRSRX has a lower initial minimum investment than BLRCX: GRSRX (0) vs BLRCX (1000). GRSRX (5.01) and BLRCX (4.77) have marching annual gain over last year. GRSRX return over 5 years is better than : 5.92 vs. BLRCX (-7.34).
BLRCXGRSRXBLRCX / GRSRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years10 years-
Gain YTD2.6173.12184%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets159M1.92B8%
Annual Yield % from dividends1.602.4665%
Returns for 1 year4.775.0195%
Returns for 3 years-12.50-12.12103%
Returns for 5 years-7.345.92-124%
Returns for 10 years4.8736.3013%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SAMG18.330.11
+0.60%
Silvercrest Asset Management Group
CRK16.09-0.03
-0.19%
Comstock Resources
MERC6.49-0.02
-0.31%
Mercer International
VINC0.19N/A
-0.31%
Vincerx Pharma
PATH13.91-0.15
-1.07%
UiPath